Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives
about
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDLigand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.Opposing effects of omega-3 and omega-6 long chain polyunsaturated Fatty acids on the expression of lipogenic genes in omental and retroperitoneal adipose depots in the ratLow-resolution molecular models reveal the oligomeric state of the PPAR and the conformational organization of its domains in solution.Antidiabetic Activities of Abutilon indicum (L.) Sweet Are Mediated by Enhancement of Adipocyte Differentiation and Activation of the GLUT1 Promoter.Long-term effects of placental growth on overweight and body composition.Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DMMolecular targets related to inflammation and insulin resistance and potential interventionsChronic dietary kudzu isoflavones improve components of metabolic syndrome in stroke-prone spontaneously hypertensive rats.Current understanding of the role of PPARγ in gastrointestinal cancersTrans-cinnamic acid increases adiponectin and the phosphorylation of AMP-activated protein kinase through G-protein-coupled receptor signaling in 3T3-L1 adipocytes.Implications for drug characterization in glucose tolerance tests without insulin: Simulation study of power and predictions using model-based analysis.Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells.Effect of linseed oil dietary supplementation on fatty acid composition and gene expression in adipose tissue of growing goats.The use of Cox-2 and PPARγ signaling in anti-cancer therapies.Nicotinic acid increases adiponectin secretion from differentiated bovine preadipocytes through G-protein coupled receptor signaling.Peroxisome Proliferator-Activated Receptor delta: A Target with a Broad Therapeutic Potential for Drug Discovery.Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
P2860
Q26752487-A6658DA1-8C5D-4D27-BDA4-D70F89425E32Q33625872-194D2602-FCD2-4C13-A761-C238453DA548Q34089697-1B9F653A-9C3D-4842-89FB-AD48BF5859B5Q34171449-C7559752-7FB3-464B-8D82-58A58B0D133BQ34982015-15E927FB-D354-4008-ABBC-768AB75D3796Q35915419-0C0AF6C7-C7E4-4584-ADAE-DBD5832C010AQ35932449-DA877A87-6A9B-44CF-9244-27447BCA35AFQ36294297-BD327C45-23D5-4C4C-A359-8763CB8C4CDDQ37445084-8AA834CF-E7E7-4F7E-8678-7659E9599730Q37626440-FF055869-A850-4AEA-8201-1E8D2E12A006Q38345638-9B091AD1-5ABE-4D74-ACAC-0B2246808B3AQ38748188-41C9B71B-D71C-4C85-ADA2-35AAE5426F0DQ41688465-17769050-BC6B-4B15-BB8E-9A29CE79F8AAQ42082128-185E13EB-0E13-48BF-B65C-5910B31A4A99Q42116284-4446A901-5142-4CE8-B896-45FFF6361E29Q42584211-058E0864-6F34-4BC1-8015-B9F6BBFD6BF9Q43148803-FF77B946-5D14-48B7-AD6B-8AB795FCF6E9Q58588579-76A037D8-A37B-4EA6-8CE7-D22FEA880A19
P2860
Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Peroxisome proliferator-activa ...... idence and future perspectives
@ast
Peroxisome proliferator-activa ...... idence and future perspectives
@en
type
label
Peroxisome proliferator-activa ...... idence and future perspectives
@ast
Peroxisome proliferator-activa ...... idence and future perspectives
@en
prefLabel
Peroxisome proliferator-activa ...... idence and future perspectives
@ast
Peroxisome proliferator-activa ...... idence and future perspectives
@en
P2860
P921
P356
P1476
Peroxisome proliferator-activa ...... idence and future perspectives
@en
P2093
Daniele Di Marzio
Francesco Chiarelli
P2860
P304
P356
10.2147/VHRM.S993
P407
P577
2008-01-01T00:00:00Z